Back to Search
PAUL PARK, PHARMD
PHARMD
Pharmacist
NPI: 1508339094Individual
Specialties, Licenses & Credentials
Research & Publications (20)
YL-I-108, a synthetic chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 murine macrophages: involvement of heme oxygenase-1 induction and blockade of activator protein-1.
PMID 19183880·Arch Pharm Res·2009
7-preclinical
KB-34, a newly synthesized chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages via heme oxygenase-1 induction and blockade of activator protein-1.
PMID 19174156·Eur J Pharmacol·2009
7-preclinical
Modulation of molecular interactions and function by rhodopsin palmitylation.
PMID 19348429·Biochemistry·2009
7-preclinical
Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.
PMID 18840266·BMC Public Health·2008
2-rct
Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.
PMID 18587272·Exp Mol Med·2008
7-preclinical
Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.
PMID 17848137·Annu Rev Pharmacol Toxicol·2008
6-review
Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin.
PMID 16958668·J Gastroenterol Hepatol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 200 W ARBOR DR
SAN DIEGO, CA 92103 - Phone
- (619) 543-2682
Quick Facts
- NPI
- 1508339094
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile